Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Since we know the science, why can't we get generic GLP-1s
Retatrutide is a research compound currently being explored in metabolic and GLP-related studies
Living with complex, invisible illnesses like Long COVID, ME/CFS, POTS, and MCAS is an incredibly frustrating and exhausting journey
Key findings from the Phase 2 trial included: Dose-dependent weight loss , with greater reductions observed at higher doses Significant improvements in waist circumference , blood pressure , and lipid profiles Reductions in fasting glucose and insulin resistance markers, though the clinical significance of these findings in people with type 2 diabetes requires further investigation Weight loss appeared to continue throughout the 48-week period without a clear plateau at the highest doses Whilst these results are encouraging, it is important to contextualise them appropriately
10.1210/clinem/dgab578 52
US$ 22.14
US$ 26.54
US$ 25.32
US$ 29.82
US$ 25.70
US$ 28.80
US$ 28.96
